ClinicalTrials.gg
Sign In
Status unknownNCT05367713BoFOCUpdated May 10, 2022

Bone Flap Osteomyelitis Following Craniectomy : Retrospective Evaluation of Clinical Presentation, Microbiological Diagnosis and Management

An observational study in Osteitis and Cranial Flap, sponsored by Hospices Civils de Lyon. Status unknown at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-05-10.

Sponsored by Hospices Civils de Lyon · Observational

The sponsor has not verified this record recently (last verified May 2022), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
160
Ages
18 Years and older
Sex
All
01

Study summary

Osteitis of the cranial flap after craniectomy is an unknown complex osteoarticular infection and there are few data concerning its epidemiology, its risk factors, and its management.

02

Conditions studied

  • Osteitis
  • Cranial Flap

Browse trials for

Keywords

  • Osteitis
  • cranial flap
03

In context

Osteitis

11 studies on the registry are indexed under Osteitis; 1 is open to participants now.

Browse Osteitis studies →

Lead sponsor

Hospices Civils de Lyon is the lead sponsor of 1,866 studies on the registry; 448 are open to participants now.

Browse Hospices Civils de Lyon studies →

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients with cranial flap osteitis after craniectomy, treated at CRIOAc Lyon.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with cranial flap osteitis after craniectomy
  • Patients who did not object to participating in the study
  • Adult patients

Exclusion criteria

Exclusion Criteria:

  • NA
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
160 participants (estimated)
Patient registry
No

Groups and cohorts

  • patients having had an osteitis of the cranial flap after craniectomy

    Other: patients having had an osteitis of the cranial flap after craniectomy

Interventions

  • Otherpatients having had an osteitis of the cranial flap after craniectomy

    description of management and failure of cranial flap after craniectomy

06

What researchers measure

Primary outcomes

  1. rate of cranial flap osteitis after craniectomy

    proportion of patients

    Time frame: between 2010 and 2021

Secondary outcomes

  1. rate of failure in management of cranial flap osteitis after craniectomy

    proportion of patients having a failure

    Time frame: between 2010 and 2021

07

Study locations

1 of 1 sites recruiting
  • Hospices Civils de Lyon
    Lyon, 69004, France
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Apr 2022 (actual). Primary completion is estimated for May 2022, 1 month after the start.

How these figures are worked out, and which studies are left out of them.

Registered
May 5, 2022
First posted
May 10, 2022
StartActual
Apr 1, 2022
Primary completionEst.
May 1, 2022
CompletionEst.
Jun 1, 2022
Last update
May 10, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 10, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05367713
Lead sponsor
Hospices Civils de Lyon
Responsible party
Sponsor
First posted
May 10, 2022
Start date
Apr 1, 2022
Primary completion
May 1, 2022 (estimated)
Completion
Jun 1, 2022 (estimated)
Last update
May 10, 2022

Study contacts

Tristan Ferry, Md,PhD
Contact
tristan.ferry@chu-lyon.fr
04 26 73 29 38
Eugenie Mabrut, CRA
Contact
eugenie.mabrut@chu-lyon.fr
04 26 73 29 38

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in May 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Osteitis →

Other studies from this sponsor

Hospices Civils de Lyon →

Start the discussion